MCL1 and leukemia: UM-36 appears to have modest selectivity for MCL-1, with similar response in BFL-1-dependent leukemia, which correlates with the in vitro binding affinity of this class of MCL-1 inhibitor showing less selective inhibition of BFL-1 [29].